Autopsy report · NCT01586728

Oxygen Therapy in Cystic Fibrosis

“lack of inclusion in the study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 1 year 10 months before it stopped.
• 8 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Assistance Publique - Hôpitaux de Paris

Sponsor type

University, hospital or other

Conditions

Cystic Fibrosis

Interventions

Air - oxygen; Oxygen - Air

Participants

8

Sites

1

Countries

France

Trials that died the same way

• Fluorescence Angiography: Planning and Monitoring of Perforator Flaps
  “The study was stopped due to lack of inclusion” (84% match in meaning)
• Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen
  “The study was stopped due to lack of inclusions” (84% match in meaning)
• New Prophylactic Maneuver: the "Pushing" Maneuver, Aiming to Reduce the Risk for Shoulder Dystocia
  “the study stopped due to the lack of inclusion.” (76% match in meaning)
• PK Intravenous Lidocaine Infusion
  “Lack of available study participants.” (76% match in meaning)
• Intra-Osseous Access in Difficult Vascular Access Cases
  “Lack of inclusion” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.